These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4608385)

  • 1. The inter-rater reliability of scales for rating symptoms and side-effects in schizophrenic patients during a drug trial.
    Andersen K; Malm U; Perris C; Rapp W; Román G
    Acta Psychiatr Scand Suppl; 1974; 249():38-42. PubMed ID: 4608385
    [No Abstract]   [Full Text] [Related]  

  • 2. The comprehesive psychopathological rating scale--CPRS--in patients with schizophrenic syndromes. Inter-rater reliability and in relation to Mårtens' S-scale.
    Jacobsson L; von Knorring L; Mattsson B; Perris C; Edenius B; Kettner B; Magnusson KE; Villemoes P
    Acta Psychiatr Scand Suppl; 1978; (271):39-44. PubMed ID: 277057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the severity of psychiatric states].
    Heimann H; Schmocker A
    Arzneimittelforschung; 1974 Jul; 24(7):1004-6. PubMed ID: 4603350
    [No Abstract]   [Full Text] [Related]  

  • 4. Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients.
    Klein DF; Rosen B
    Arch Gen Psychiatry; 1973 Oct; 29(4):480-5. PubMed ID: 4583948
    [No Abstract]   [Full Text] [Related]  

  • 5. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
    Kølbæk P; Blicher AB; Buus CW; Feller SG; Holm T; Dines D; O'Leary KM; Sørensen RS; Opler M; Correll CU; Mors O; Bech P; Østergaard SD
    Nord J Psychiatry; 2018 Aug; 72(6):431-436. PubMed ID: 30037286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 7. Response threshold to levodopa in psychiatric patients.
    Sathananthan G; Angrist BM; Gershon S
    Biol Psychiatry; 1973 Oct; 7(2):139-46. PubMed ID: 4584028
    [No Abstract]   [Full Text] [Related]  

  • 8. A search for responders to niacin supplementation.
    Wittenborn JR
    Arch Gen Psychiatry; 1974 Oct; 31(4):547-52. PubMed ID: 4607587
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 10. Rating of negative symptoms using the High Royds Evaluation of Negativity (HEN) scale.
    Mortimer AM; McKenna PJ; Lund CE; Mannuzza S
    Br J Psychiatry Suppl; 1989 Nov; (7):89-92. PubMed ID: 2619986
    [No Abstract]   [Full Text] [Related]  

  • 11. Rating affective flattening from videotaped interviews.
    Waltrip RW; Strauss ME; Summerfelt A; Heinrichs D; Kirkpatrick B; Jauch D; Oltmanns TF
    Psychiatry Res; 1989 Feb; 27(2):199-205. PubMed ID: 2710865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 13. Inter-rater reliability of twelve diagnostic systems of schizophrenia.
    Helmes E; Landmark J; Kazarian SS
    J Nerv Ment Dis; 1983 May; 171(5):307-11. PubMed ID: 6854293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
    Woggon B
    Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aqueous pineal extract in chronic schizophrenia.
    Bigelow LB
    Biol Psychiatry; 1974 Feb; 8(1):5-15. PubMed ID: 4592789
    [No Abstract]   [Full Text] [Related]  

  • 16. A carbamazepine trial in chronic, treatment-refractory schizophrenia.
    Sramek J; Herrera J; Costa J; Heh C; Tran-Johnson T; Simpson G
    Am J Psychiatry; 1988 Jun; 145(6):748-50. PubMed ID: 3285702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A standard-controlled clinical study with trazodone in schizophrenic patients.
    Deutsch M; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):13-4. PubMed ID: 329321
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia.
    Moroji T; Watanabe N; Aoki N; Itoh S
    Arch Gen Psychiatry; 1982 Apr; 39(4):485-6. PubMed ID: 7039550
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat).
    Lindström E; Lewander T; Malm U; Malt UF; Lublin H; Ahlfors UG
    Nord J Psychiatry; 2001; 55 Suppl 44():5-69. PubMed ID: 11860666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of chlorprothixene and haloperidol in acute schizophrenia.
    Marjerrison G; Bowman R; Keogh RP
    Can Psychiatr Assoc J; 1971 Dec; 16(6):533-6. PubMed ID: 4947173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.